Back to search
FDAFDA · Food and drugs·Recall number D-1054-2020

Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida

Published April 1, 2020 · Recall initiated: March 10, 2020

Summary

FDA records drug Class II recall D-1054-2020, published April 1, 2020 and initiated March 10, 2020. Recalling firm: Matthew 7:25 Inc dba Thrive Pharmacy; Status: Terminated; Reported quantity: 89 troches; Lot: Lot: 191217A Exp. 06/14/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Matthew 7:25 Inc dba Thrive Pharmacy
Distributor
Florida
Lot
Lot: 191217A Exp. 06/14/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Buprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, Thrive Pharmacy 2863 St Johns Bluff RD. South # 135 Jacksonville, Florida recalled?

Yes. FDA published recall D-1054-2020 on April 1, 2020. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Telephone